Walleye Capital’s Acadia Healthcare ACHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.57M Sell
109,664
-1,667,407
-94% -$30.2M 0.01% 1271
2025
Q4
$25.2M Buy
1,777,071
+707,022
+66% +$13.4M 0.08% 218
2025
Q3
$26.5M Buy
1,070,049
+1,500
+0.1% +$33.5K 0.1% 171
2025
Q2
$24.2M Buy
1,068,549
+188,823
+21% +$4.47M 0.09% 173
2025
Q1
$26.7M Buy
879,726
+488,265
+125% +$18.6M 0.12% 133
2024
Q4
$15.5M Buy
391,461
+354,516
+960% +$16M 0.04% 415
2024
Q3
$2.34M Buy
36,945
+35,189
+2,004% +$2.54M ﹤0.01% 1791
2024
Q2
$119K Buy
+1,756
New +$123K ﹤0.01% 4636
2023
Q2
Sell
-122,192
Closed -$8.83M 4242
2023
Q1
$8.83M Sell
122,192
-30,120
-20% -$2.35M 0.13% 170
2022
Q4
$12.5M Buy
+152,312
New +$12.6M 0.23% 91
2022
Q2
Sell
-3,295
Closed -$216K 2311
2022
Q1
$216K Buy
+3,295
New +$191K 0.01% 1471
2019
Q4
Sell
-2,900
Closed -$90K 1728
2019
Q3
$90K Buy
+2,900
New +$88.3K 0.01% 1462

Other funds holding ACHC

Walleye Capital's ACHC Position: Q1 2026 in Review

Walleye Capital reduced its Acadia Healthcare (ACHC) stake by 94% in Q1 2026, selling an estimated $30.2M and leaving 109,664 shares worth $2.57M. The position accounts for 0.01% of the portfolio, ranked #1271.

Walleye Capital first reported a position in ACHC in Q3 2019 and has held it in 12 quarters since. The position peaked at $26.7M in Q1 2025. 295 funds tracked by Wall St. Rank hold ACHC as of Q1 2026.

  • Walleye Capital held 109,664 shares of Acadia Healthcare worth $2.57M as of Q1 2026.
  • Walleye Capital sold 1,667,407 Acadia Healthcare shares in Q1 2026, an estimated $30.2M.
  • Acadia Healthcare made up 0.01% of Walleye Capital's portfolio in Q1 2026, its #1271 holding.
  • Walleye Capital first reported a position in Acadia Healthcare in Q3 2019 and has held it in 12 quarters since.
  • Walleye Capital's Acadia Healthcare position peaked at $26.7M in Q1 2025.
  • 295 funds tracked by Wall St. Rank held Acadia Healthcare as of Q1 2026.

Based on Walleye Capital's 13F filing for Q1 2026, filed 11 May 2026.